ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC Pharmaceuticals (Nasdaq: ORIC), a clinical stage oncology company, has announced its participation in five major investor conferences in September 2025. The company will engage in fireside chats and one-on-one meetings at the Citi Biopharma Back to School Summit, Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, and Baird Global Healthcare Conference.
Webcasts of the fireside chat discussions will be accessible through ORIC's investor relations website, with replays available for 90 days after each event.
ORIC Pharmaceuticals (Nasdaq: ORIC), società clinica nel settore oncologico, ha comunicato la sua partecipazione a cinque importanti conferenze per investitori a settembre 2025. La società parteciperà a discussioni informali e a incontri one-to-one al Citi Biopharma Back to School Summit, al Wells Fargo Healthcare Conference, al Cantor Global Healthcare Conference, al Morgan Stanley Global Healthcare Conference e al Baird Global Healthcare Conference.
I webcast delle fireside chat saranno disponibili sul sito per gli investitori di ORIC, con le registrazioni fruibili per 90 giorni dopo ciascun evento.
ORIC Pharmaceuticals (Nasdaq: ORIC), una compañía oncológica en fase clínica, ha anunciado su participación en cinco importantes conferencias para inversores en septiembre de 2025. La empresa participará en charlas informales y reuniones individuales en el Citi Biopharma Back to School Summit, el Wells Fargo Healthcare Conference, el Cantor Global Healthcare Conference, el Morgan Stanley Global Healthcare Conference y el Baird Global Healthcare Conference.
Los webcasts de las charlas estarán accesibles a través del sitio web de relaciones con inversores de ORIC, y las repeticiones estarán disponibles durante 90 días tras cada evento.
ORIC Pharmaceuticals (Nasdaq: ORIC), 임상 단계의 종양학 기업인 ORIC가 2025년 9월에 열리는 주요 투자자 콘퍼런스 5곳에 참가한다고 발표했습니다. 회사는 Citi Biopharma Back to School Summit, Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, Baird Global Healthcare Conference에서 파이어사이드 채팅과 일대일 미팅에 참석할 예정입니다.
파이어사이드 채팅의 웹캐스트는 ORIC 투자자 관계 웹사이트를 통해 시청할 수 있으며, 각 행사가 끝난 후 90일 동안 다시보기를 제공할 예정입니다.
ORIC Pharmaceuticals (Nasdaq: ORIC), une société oncologique en phase clinique, a annoncé sa participation à cinq grandes conférences investisseurs en septembre 2025. La société interviendra lors de discussions au coin du feu et de réunions individuelles au Citi Biopharma Back to School Summit, à la Wells Fargo Healthcare Conference, à la Cantor Global Healthcare Conference, à la Morgan Stanley Global Healthcare Conference et à la Baird Global Healthcare Conference.
Les webcasts des discussions seront accessibles via le site relations investisseurs d'ORIC, et les rediffusions resteront disponibles pendant 90 jours après chaque événement.
ORIC Pharmaceuticals (Nasdaq: ORIC), ein klinisch tätiges Onkologieunternehmen, hat seine Teilnahme an fünf großen Investorenkonferenzen im September 2025 bekanntgegeben. Das Unternehmen wird an Fireside-Chats sowie Einzelgesprächen beim Citi Biopharma Back to School Summit, der Wells Fargo Healthcare Conference, der Cantor Global Healthcare Conference, der Morgan Stanley Global Healthcare Conference und der Baird Global Healthcare Conference teilnehmen.
Webcasts der Fireside-Chats werden über die Investor-Relations-Website von ORIC abrufbar sein; Wiederholungen stehen jeweils 90 Tage nach der Veranstaltung zur Verfügung.
- None.
- None.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in September:
- Citi's 2025 Biopharma Back to School Summit – Participating in a fireside chat on Wednesday, September 3, 2025, at 4:00 p.m. ET. Management will also be participating in one-on-one meetings.
- 2025 Wells Fargo Healthcare Conference – Participating in a fireside chat on Thursday, September 4, 2025, at 2:15 p.m. ET. Management will also be participating in one-on-one meetings.
- Cantor Global Healthcare Conference 2025 – Participating in a fireside chat on Friday, September 5, 2025, at 8:35 a.m. ET. Management will also be participating in one-on-one meetings.
- Morgan Stanley 23rd Annual Global Healthcare Conference – Participating in one-on-one meetings on Tuesday, September 9, 2025.
- Baird 2025 Global Healthcare Conference – Participating in a fireside chat on Wednesday, September 10, 2025, at 1:25 p.m. ET. Management will also be participating in one-on-one meetings.
Webcasts of the fireside chat discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib (ORIC-114), a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
Contact:
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com
FAQ
When is ORIC Pharmaceuticals presenting at the Citi Biopharma Summit 2025?
How can investors access ORIC Pharmaceuticals' conference presentations?
Which investor conferences is ORIC attending in September 2025?
What type of company is ORIC Pharmaceuticals?
